Annual SGA
$66.98 M
-$50.32 M-42.90%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual SGA is $66.98 million, with the most recent change of -$50.32 million (-42.90%) on December 31, 2023.
- During the last 3 years, LYEL annual SGA has risen by +$20.10 million (+42.88%).
- LYEL annual SGA is now -42.90% below its all-time high of $117.31 million, reached on December 31, 2022.
Performance
LYEL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$11.77 M
-$487.00 K-3.97%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly SGA is $11.77 million, with the most recent change of -$487.00 thousand (-3.97%) on September 30, 2024.
- Over the past year, LYEL quarterly SGA has dropped by -$1.40 million (-10.62%).
- LYEL quarterly SGA is now -65.81% below its all-time high of $34.42 million, reached on March 31, 2022.
Performance
LYEL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.33 B
-$203.99 M-4.95%
September 30, 2024
Summary
- As of February 7, 2025, LYEL TTM SGA is -$4.33 billion, with the most recent change of -$203.99 million (-4.95%) on September 30, 2024.
- Over the past year, LYEL TTM SGA has dropped by -$4.39 billion (-6559.33%).
- LYEL TTM SGA is now -1194.85% below its all-time high of -$334.14 million.
Performance
LYEL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LYEL Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -42.9% | -10.6% | -6559.3% |
3 y3 years | +42.9% | -63.1% | -4958.3% |
5 y5 years | +71.1% | -38.4% | -6820.3% |
LYEL Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -42.9% | at low | -65.8% | at low | -124.7% | at low |
5 y | 5-year | -42.9% | +71.1% | -65.8% | +32.5% | -1194.8% | at low |
alltime | all time | -42.9% | +71.1% | -65.8% | +32.5% | -1194.8% | at low |
Lyell Immunopharma Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $11.77 M(-4.0%) | $50.69 M(-6.9%) |
Jun 2024 | - | $12.26 M(-9.2%) | $54.42 M(-11.1%) |
Mar 2024 | - | $13.49 M(+2.5%) | $61.20 M(-8.6%) |
Dec 2023 | $66.98 M(-42.9%) | $13.17 M(-15.1%) | $66.98 M(-16.4%) |
Sep 2023 | - | $15.51 M(-18.5%) | $80.16 M(-11.7%) |
Jun 2023 | - | $19.03 M(-1.3%) | $90.74 M(-11.2%) |
Mar 2023 | - | $19.28 M(-26.8%) | $102.17 M(-12.9%) |
Dec 2022 | $117.31 M | $26.35 M(+1.0%) | $117.31 M(-4.5%) |
Sep 2022 | - | $26.08 M(-14.3%) | $122.83 M(+4.1%) |
Jun 2022 | - | $30.45 M(-11.5%) | $117.99 M(+10.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $34.42 M(+8.0%) | $106.65 M(+19.8%) |
Dec 2021 | $89.06 M(+90.0%) | $31.87 M(+50.1%) | $89.06 M(+23.6%) |
Sep 2021 | - | $21.24 M(+11.1%) | $72.05 M(+11.9%) |
Jun 2021 | - | $19.11 M(+13.6%) | $64.38 M(+17.4%) |
Mar 2021 | - | $16.83 M(+13.2%) | $54.83 M(+17.0%) |
Dec 2020 | $46.88 M(+19.7%) | - | - |
Dec 2020 | - | $14.87 M(+9.6%) | $46.88 M(+46.4%) |
Sep 2020 | - | $13.57 M(+41.9%) | $32.01 M(+73.6%) |
Jun 2020 | - | $9.56 M(+7.7%) | $18.44 M(+107.7%) |
Mar 2020 | - | $8.88 M | $8.88 M |
Dec 2019 | $39.15 M | - | - |
FAQ
- What is Lyell Immunopharma annual SGA?
- What is the all time high annual SGA for Lyell Immunopharma?
- What is Lyell Immunopharma annual SGA year-on-year change?
- What is Lyell Immunopharma quarterly SGA?
- What is the all time high quarterly SGA for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly SGA year-on-year change?
- What is Lyell Immunopharma TTM SGA?
- What is the all time high TTM SGA for Lyell Immunopharma?
- What is Lyell Immunopharma TTM SGA year-on-year change?
What is Lyell Immunopharma annual SGA?
The current annual SGA of LYEL is $66.98 M
What is the all time high annual SGA for Lyell Immunopharma?
Lyell Immunopharma all-time high annual SGA is $117.31 M
What is Lyell Immunopharma annual SGA year-on-year change?
Over the past year, LYEL annual SGA has changed by -$50.32 M (-42.90%)
What is Lyell Immunopharma quarterly SGA?
The current quarterly SGA of LYEL is $11.77 M
What is the all time high quarterly SGA for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly SGA is $34.42 M
What is Lyell Immunopharma quarterly SGA year-on-year change?
Over the past year, LYEL quarterly SGA has changed by -$1.40 M (-10.62%)
What is Lyell Immunopharma TTM SGA?
The current TTM SGA of LYEL is -$4.33 B
What is the all time high TTM SGA for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM SGA is -$334.14 M
What is Lyell Immunopharma TTM SGA year-on-year change?
Over the past year, LYEL TTM SGA has changed by -$4.39 B (-6559.33%)